Advanced injectable nanocomposite biomaterials with therapeutic-regenerative activity for the treatment of bone metastases
Project objectives
The main cause of death in patients with malignant tumors does not derive from the primary disease, but from distant metastases. Individuals with advanced stage breast and prostate cancer frequently develop bone metastases associated with severe pain and osteolytic phenomena, with increased bone fragility and fracture risk. To date, chemo- and radio-therapeutic treatments constitute the main approaches to stop the progression of metastases, even if these solutions have the great limitation of inhibiting both the replication of neoplastic and healthy cells without distinction, causing numerous side effects that reduce further improve the patient's quality of life.
Currently, no material has been described in the literature which alone is able to arrest the growth of tumor cells and, at the same time, to stimulate the proliferation and osteogenic differentiation of healthy cells with consequent formation of new bone tissue.
The objective of the project is to develop materials for the treatment of injectable bone metastases using minimally invasive surgical approaches. The antiblastic and osteoinductive properties of materials such as graphene oxide (GO) and exfoliated black phosphorus (bP) will be tested. Recent studies have demonstrated the anti-tumor capabilities of these biomaterials thanks to their ability to generate oxygen radicals (ROS) upon exposure to infrared light. bP is completely biodegradable and non-toxic, while GO has excellent mechanical properties which make it ideal for the development of biocomposites for bone regeneration, especially when combined with natural polymers such as hydroxyapatite.
The main objective of the project is the development of bifunctional injectable systems with anti-tumor activity, which will first be tested in vitro using models reproducing the tumor microenvironment and subsequently in vivo on a human model of bone metastasis.
Start and end date
2019 - 2023
Project managers
Prof. Gianluca Vadalà- Associate Professor in Orthopedics and Traumatology
Coordinating institution of the project
National Research Center
Other Institutions involved in the project
- Politecnico di Milano
- Università Campus Bio-Medico di Roma
- University of Rome “Tor Vergata” Interdepartmental Service Center – Station for Animal Technology
Funding source
Call for Research PRIN–MIUR